- Report
- February 2024
- 111 Pages
Global
From €4235EUR$4,750USD£3,690GBP
- Report
- February 2024
- 120 Pages
Global
From €4235EUR$4,750USD£3,690GBP
- Report
- February 2024
- 71 Pages
Europe
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 120 Pages
Global
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 106 Pages
Global
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 110 Pages
Global
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 71 Pages
Italy
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 100 Pages
Global
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 120 Pages
Global
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 69 Pages
United Kingdom
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 111 Pages
Global
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 130 Pages
Global
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 146 Pages
Global
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 75 Pages
South Korea
From €4235EUR$4,750USD£3,690GBP
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 69 Pages
India
From €4235EUR$4,750USD£3,690GBP
- Report
- April 2023
- 61 Pages
Mexico
From €4235EUR$4,750USD£3,690GBP
- Report
- January 2022
- 120 Pages
Global
From €4235EUR$4,750USD£3,690GBP
- Report
- January 2021
- 245 Pages
Global
From €3209EUR$3,600USD£2,796GBP
- Report
- September 2025
- 150 Pages
Canada
From €3432EUR$3,850USD£2,991GBP

Retinopathy is a medical condition that affects the retina, the light-sensitive tissue at the back of the eye. It is a leading cause of blindness and visual impairment worldwide. Optical treatments for retinopathy include laser photocoagulation, intravitreal injections, and vitrectomy. Laser photocoagulation is used to reduce the risk of vision loss by sealing off leaking blood vessels in the retina. Intravitreal injections are used to deliver medications directly to the retina to reduce swelling and inflammation. Vitrectomy is a surgical procedure used to remove scar tissue and other debris from the vitreous cavity.
Companies in the retinopathy market include Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Heidelberg Engineering, Nidek, Optos, Topcon, and Zeiss. Show Less Read more